Changes in serial laboratory test results in snakebite patients

when can we safely exclude envenoming?

Graham Ireland, Simon Brown, Nicholas Buckley, Jeff Stormer, Bart Currie, Julian White, David Spain, Geoffrey Isbister

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Objectives: To determine which laboratory tests are first associated with severe envenoming after a snakebite, when (ie, how long after the bite) the test results become abnormal, and whether this can determine a safe observation period after suspected snakebite.

Design, patients and setting: Prospective cohort study of 478 patients with suspected or confirmed snakebite recruited to the Australian Snakebite Project from January 2002 to April 2009, who had at least three sets of laboratory test results and at least 12 hours of observation in hospital after the bite. Severe envenoming was defined as venom-induced consumption coagulopathy (VICC), myotoxicity, neurotoxicity or thrombotic microangiopathy.

Main outcome measures:
International normalised ratio (INR), activated partial thromboplastin time (aPTT), creatine kinase (CK) level, and neurological examination.

Results: There were 240 patients with severe envenoming, 75 with minor envenoming and 163 non-envenomed patients. Of 206 patients with VICC, 178 had an INR > 1.2 (abnormal) on admission, and the remaining 28 had an INR > 1.2 within 12 hours of the bite. Of 33 patients with myotoxicity, a combination of CK > 250 U/L and an abnormal aPTT identified all but two cases by 12 hours; one of these two was identified within 12 hours by leukocytosis. Nine cases of isolated neurotoxicity had a median time of onset after the bite of 4 hours (range, 35 min - 12 h). The combination of serial INR, aPTT and CK tests and repeated neurological examination identified 213 of 222 severe envenoming cases (96%) by 6 hours and 238 of 240 (99%) by 12 hours.

Conclusion: Laboratory parameters (INR, aPTT and CK) and neurological reassessments identified nearly all severe envenoming cases within 12 hours of the bite, even in this conservative analysis that assumed normal test results if the test was not done.
Original languageEnglish
Pages (from-to)285-290
Number of pages6
JournalMedical Journal of Australia
Volume193
Issue number5
Publication statusPublished - 6 Sep 2010

Fingerprint

Snake Bites
International Normalized Ratio
Bites and Stings
Partial Thromboplastin Time
Creatine Kinase
Disseminated Intravascular Coagulation
Venoms
Neurologic Examination
Observation
Thrombotic Microangiopathies
Leukocytosis
Cohort Studies
Outcome Assessment (Health Care)
Prospective Studies

Cite this

Ireland, G., Brown, S., Buckley, N., Stormer, J., Currie, B., White, J., ... Isbister, G. (2010). Changes in serial laboratory test results in snakebite patients: when can we safely exclude envenoming? Medical Journal of Australia, 193(5), 285-290.
Ireland, Graham ; Brown, Simon ; Buckley, Nicholas ; Stormer, Jeff ; Currie, Bart ; White, Julian ; Spain, David ; Isbister, Geoffrey. / Changes in serial laboratory test results in snakebite patients : when can we safely exclude envenoming?. In: Medical Journal of Australia. 2010 ; Vol. 193, No. 5. pp. 285-290.
@article{11ecfec8f6de4b6aa41b45b91aabba60,
title = "Changes in serial laboratory test results in snakebite patients: when can we safely exclude envenoming?",
abstract = "Objectives: To determine which laboratory tests are first associated with severe envenoming after a snakebite, when (ie, how long after the bite) the test results become abnormal, and whether this can determine a safe observation period after suspected snakebite. Design, patients and setting: Prospective cohort study of 478 patients with suspected or confirmed snakebite recruited to the Australian Snakebite Project from January 2002 to April 2009, who had at least three sets of laboratory test results and at least 12 hours of observation in hospital after the bite. Severe envenoming was defined as venom-induced consumption coagulopathy (VICC), myotoxicity, neurotoxicity or thrombotic microangiopathy. Main outcome measures: International normalised ratio (INR), activated partial thromboplastin time (aPTT), creatine kinase (CK) level, and neurological examination. Results: There were 240 patients with severe envenoming, 75 with minor envenoming and 163 non-envenomed patients. Of 206 patients with VICC, 178 had an INR > 1.2 (abnormal) on admission, and the remaining 28 had an INR > 1.2 within 12 hours of the bite. Of 33 patients with myotoxicity, a combination of CK > 250 U/L and an abnormal aPTT identified all but two cases by 12 hours; one of these two was identified within 12 hours by leukocytosis. Nine cases of isolated neurotoxicity had a median time of onset after the bite of 4 hours (range, 35 min - 12 h). The combination of serial INR, aPTT and CK tests and repeated neurological examination identified 213 of 222 severe envenoming cases (96{\%}) by 6 hours and 238 of 240 (99{\%}) by 12 hours. Conclusion: Laboratory parameters (INR, aPTT and CK) and neurological reassessments identified nearly all severe envenoming cases within 12 hours of the bite, even in this conservative analysis that assumed normal test results if the test was not done.",
keywords = "creatine kinase, D dimer, abdominal pain, adult, article, artificial ventilation, controlled study, creatine kinase blood level, diaphoresis, diaphragm paralysis, diarrhea, disseminated intravascular clotting, envenomation, female, headache, hemolysis, human, international normalized ratio, intubation, kidney failure, laboratory test, leukocytosis, major clinical study, male, methodology, muscle toxicity, myalgia, nausea, neurologic examination, neurotoxicity, outcome assessment, partial thromboplastin time, prospective study, snakebite, thrombocytopenia, thrombotic thrombocytopenic purpura, toxicity, venom induced consumption coagulopathy, vomiting, algorithm, blood, clinical pathway, complication, Disseminated Intravascular Coagulation, middle aged, young adult, Adult, Algorithms, Creatine Kinase, Critical Pathways, Female, Humans, International Normalized Ratio, Male, Middle Aged, Neurologic Examination, Partial Thromboplastin Time, Prospective Studies, Snake Bites, Young Adult",
author = "Graham Ireland and Simon Brown and Nicholas Buckley and Jeff Stormer and Bart Currie and Julian White and David Spain and Geoffrey Isbister",
year = "2010",
month = "9",
day = "6",
language = "English",
volume = "193",
pages = "285--290",
journal = "Medical Journal of Australia",
issn = "0025-729X",
publisher = "Australasian Medical Publishing Company",
number = "5",

}

Ireland, G, Brown, S, Buckley, N, Stormer, J, Currie, B, White, J, Spain, D & Isbister, G 2010, 'Changes in serial laboratory test results in snakebite patients: when can we safely exclude envenoming?', Medical Journal of Australia, vol. 193, no. 5, pp. 285-290.

Changes in serial laboratory test results in snakebite patients : when can we safely exclude envenoming? / Ireland, Graham; Brown, Simon; Buckley, Nicholas; Stormer, Jeff; Currie, Bart; White, Julian; Spain, David; Isbister, Geoffrey.

In: Medical Journal of Australia, Vol. 193, No. 5, 06.09.2010, p. 285-290.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Changes in serial laboratory test results in snakebite patients

T2 - when can we safely exclude envenoming?

AU - Ireland, Graham

AU - Brown, Simon

AU - Buckley, Nicholas

AU - Stormer, Jeff

AU - Currie, Bart

AU - White, Julian

AU - Spain, David

AU - Isbister, Geoffrey

PY - 2010/9/6

Y1 - 2010/9/6

N2 - Objectives: To determine which laboratory tests are first associated with severe envenoming after a snakebite, when (ie, how long after the bite) the test results become abnormal, and whether this can determine a safe observation period after suspected snakebite. Design, patients and setting: Prospective cohort study of 478 patients with suspected or confirmed snakebite recruited to the Australian Snakebite Project from January 2002 to April 2009, who had at least three sets of laboratory test results and at least 12 hours of observation in hospital after the bite. Severe envenoming was defined as venom-induced consumption coagulopathy (VICC), myotoxicity, neurotoxicity or thrombotic microangiopathy. Main outcome measures: International normalised ratio (INR), activated partial thromboplastin time (aPTT), creatine kinase (CK) level, and neurological examination. Results: There were 240 patients with severe envenoming, 75 with minor envenoming and 163 non-envenomed patients. Of 206 patients with VICC, 178 had an INR > 1.2 (abnormal) on admission, and the remaining 28 had an INR > 1.2 within 12 hours of the bite. Of 33 patients with myotoxicity, a combination of CK > 250 U/L and an abnormal aPTT identified all but two cases by 12 hours; one of these two was identified within 12 hours by leukocytosis. Nine cases of isolated neurotoxicity had a median time of onset after the bite of 4 hours (range, 35 min - 12 h). The combination of serial INR, aPTT and CK tests and repeated neurological examination identified 213 of 222 severe envenoming cases (96%) by 6 hours and 238 of 240 (99%) by 12 hours. Conclusion: Laboratory parameters (INR, aPTT and CK) and neurological reassessments identified nearly all severe envenoming cases within 12 hours of the bite, even in this conservative analysis that assumed normal test results if the test was not done.

AB - Objectives: To determine which laboratory tests are first associated with severe envenoming after a snakebite, when (ie, how long after the bite) the test results become abnormal, and whether this can determine a safe observation period after suspected snakebite. Design, patients and setting: Prospective cohort study of 478 patients with suspected or confirmed snakebite recruited to the Australian Snakebite Project from January 2002 to April 2009, who had at least three sets of laboratory test results and at least 12 hours of observation in hospital after the bite. Severe envenoming was defined as venom-induced consumption coagulopathy (VICC), myotoxicity, neurotoxicity or thrombotic microangiopathy. Main outcome measures: International normalised ratio (INR), activated partial thromboplastin time (aPTT), creatine kinase (CK) level, and neurological examination. Results: There were 240 patients with severe envenoming, 75 with minor envenoming and 163 non-envenomed patients. Of 206 patients with VICC, 178 had an INR > 1.2 (abnormal) on admission, and the remaining 28 had an INR > 1.2 within 12 hours of the bite. Of 33 patients with myotoxicity, a combination of CK > 250 U/L and an abnormal aPTT identified all but two cases by 12 hours; one of these two was identified within 12 hours by leukocytosis. Nine cases of isolated neurotoxicity had a median time of onset after the bite of 4 hours (range, 35 min - 12 h). The combination of serial INR, aPTT and CK tests and repeated neurological examination identified 213 of 222 severe envenoming cases (96%) by 6 hours and 238 of 240 (99%) by 12 hours. Conclusion: Laboratory parameters (INR, aPTT and CK) and neurological reassessments identified nearly all severe envenoming cases within 12 hours of the bite, even in this conservative analysis that assumed normal test results if the test was not done.

KW - creatine kinase

KW - D dimer

KW - abdominal pain

KW - adult

KW - article

KW - artificial ventilation

KW - controlled study

KW - creatine kinase blood level

KW - diaphoresis

KW - diaphragm paralysis

KW - diarrhea

KW - disseminated intravascular clotting

KW - envenomation

KW - female

KW - headache

KW - hemolysis

KW - human

KW - international normalized ratio

KW - intubation

KW - kidney failure

KW - laboratory test

KW - leukocytosis

KW - major clinical study

KW - male

KW - methodology

KW - muscle toxicity

KW - myalgia

KW - nausea

KW - neurologic examination

KW - neurotoxicity

KW - outcome assessment

KW - partial thromboplastin time

KW - prospective study

KW - snakebite

KW - thrombocytopenia

KW - thrombotic thrombocytopenic purpura

KW - toxicity

KW - venom induced consumption coagulopathy

KW - vomiting

KW - algorithm

KW - blood

KW - clinical pathway

KW - complication

KW - Disseminated Intravascular Coagulation

KW - middle aged

KW - young adult

KW - Adult

KW - Algorithms

KW - Creatine Kinase

KW - Critical Pathways

KW - Female

KW - Humans

KW - International Normalized Ratio

KW - Male

KW - Middle Aged

KW - Neurologic Examination

KW - Partial Thromboplastin Time

KW - Prospective Studies

KW - Snake Bites

KW - Young Adult

UR - http://www.scopus.com/inward/record.url?scp=77957686670&partnerID=8YFLogxK

M3 - Article

VL - 193

SP - 285

EP - 290

JO - Medical Journal of Australia

JF - Medical Journal of Australia

SN - 0025-729X

IS - 5

ER -